MA
PRME icon

Mutual Advisors’s Prime Medicine PRME Stock Holding History

Mutual Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$166K Sell
45,000
-200
-0.4% -$664 ﹤0.01% 1348
2026
Q1 		$157K Hold
45,200
– – ﹤0.01% 1286
2025
Q4 		$157K Hold
45,200
– – ﹤0.01% 1263
2025
Q3 		$243K Hold
45,200
– – 0.01% 1143
2025
Q2 		$190K Buy
+45,200
New +$69.7K ﹤0.01% 1137

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Mutual Advisors's PRME Position: Q2 2026 in Review

Mutual Advisors reduced its Prime Medicine (PRME) stake by 0.44% in Q2 2026, selling an estimated $664 and leaving 45,000 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.

Mutual Advisors first reported a position in PRME in Q2 2025 and has held it in 5 quarters since. The position peaked at $243K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Mutual Advisors held 45,000 shares of Prime Medicine worth $166K as of Q2 2026.
  • Mutual Advisors sold 200 Prime Medicine shares in Q2 2026, an estimated $664.
  • Prime Medicine made up ﹤0.01% of Mutual Advisors's portfolio in Q2 2026, its #1348 holding.
  • Mutual Advisors first reported a position in Prime Medicine in Q2 2025 and has held it in 5 quarters since.
  • Mutual Advisors's Prime Medicine position peaked at $243K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.